FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention describes diazepane derivative of the general formula (I)
or its pharmaceutically acceptable salt wherein ring B means phenyl; ring A means pyridyl substituted with halogen atom optionally, or phenyl substituted optionally with lower alkyl, lower alkoxy-group or halogen atom; X1 represents -C(=O)-NR2- or -NR2-C(=O)- wherein R2 means hydrogen atom; X2 represents -C(=O)-NR3- or NR3-C(=O)- wherein R3 means hydrogen atom; R represents hydrogen atom or halogen atom; R1 means lower alkyl. Also, invention relates to a pharmaceutical composition and inhibitor of blood coagulation activated factor X that can be used for prophylaxis and treatment of patients suffering with thrombosis or embolism.
EFFECT: valuable medicinal properties of compound.
5 cl, 5 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED DERIVATIVES OF BENZENE OR THEIR SALTS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2001 |
|
RU2276137C2 |
| BENZENE DERIVATIVE OR SALT THEREOF | 2006 |
|
RU2395496C2 |
| SULFONAMIDE GROUPS-CONTAINING HETEROCYCLIC COMPOUND, INTERMEDIATE COMPOUND AND ANTI-ANGIOGENIC AGENT BASED ON THEREOF | 2000 |
|
RU2239631C2 |
| DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND METHOD FOR TREATMENT OF DISORDERS WITH NEURONS INJURY | 2000 |
|
RU2241709C2 |
| DERIVATIVE OF AMINOBENZOIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALT | 1993 |
|
RU2067979C1 |
| SUBSTITUTED BENZENE COMPOUNDS | 2013 |
|
RU2658919C2 |
| IMIDAZOLE COMPOUNDS, METHOD FOR THEIR PREPARING, METHOD FOR INHIBITION OF ACTIVITY OF ADENOSINE DEAMINASE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1999 |
|
RU2243220C2 |
| AMINOTRIAZOLOPYRIDINES AND USING THEM AS KINASE INHIBITORS | 2009 |
|
RU2552642C2 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF DISEASE TREATMENT INTERMEDIARY AGENT OF THAT IS TACHIKININ | 1991 |
|
RU2073683C1 |
| 5-MEMBERED HETEROCYCLIC COMPOUND AND ITS APPLICATION FOR MEDICINAL PURPOSES | 2008 |
|
RU2515968C2 |
